Xiaoyan Ding

838 total citations
37 papers, 607 citations indexed

About

Xiaoyan Ding is a scholar working on Hepatology, Cancer Research and Epidemiology. According to data from OpenAlex, Xiaoyan Ding has authored 37 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 12 papers in Cancer Research and 10 papers in Epidemiology. Recurrent topics in Xiaoyan Ding's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Liver Disease Diagnosis and Treatment (7 papers) and Cancer Mechanisms and Therapy (5 papers). Xiaoyan Ding is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Liver Disease Diagnosis and Treatment (7 papers) and Cancer Mechanisms and Therapy (5 papers). Xiaoyan Ding collaborates with scholars based in China and United States. Xiaoyan Ding's co-authors include Ying Fan, Wei Sun, Jinglong Chen, Ying Teng, Wendong Li, Binghe Xu, Fei Ma, Wei Zheng, Wei Li and Pin Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Xiaoyan Ding

36 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyan Ding China 13 183 158 150 148 102 37 607
Catia Lippolis Italy 13 94 0.5× 138 0.9× 165 1.1× 128 0.9× 64 0.6× 19 476
Liangcai Wu China 15 81 0.4× 166 1.1× 277 1.8× 200 1.4× 80 0.8× 24 635
Chen Huang China 16 133 0.7× 271 1.7× 326 2.2× 214 1.4× 109 1.1× 38 843
Annalisa Lorenzato Italy 13 70 0.4× 137 0.9× 369 2.5× 234 1.6× 111 1.1× 22 698
Gonzalo Carrasco-Aviño Chile 15 112 0.6× 185 1.2× 266 1.8× 152 1.0× 51 0.5× 40 751
Thomas Grünberger Austria 15 201 1.1× 188 1.2× 144 1.0× 47 0.3× 54 0.5× 29 689
Thorsten Lehmann Germany 15 230 1.3× 46 0.3× 159 1.1× 80 0.5× 92 0.9× 26 697
Elizabeth Pang Hong Kong 13 76 0.4× 229 1.4× 381 2.5× 206 1.4× 55 0.5× 24 740
Yifeng Tao China 14 94 0.5× 90 0.6× 190 1.3× 105 0.7× 16 0.2× 37 512
Takehiro Sando Japan 8 97 0.5× 275 1.7× 343 2.3× 120 0.8× 45 0.4× 13 932

Countries citing papers authored by Xiaoyan Ding

Since Specialization
Citations

This map shows the geographic impact of Xiaoyan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Ding more than expected).

Fields of papers citing papers by Xiaoyan Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Ding. The network helps show where Xiaoyan Ding may publish in the future.

Co-authorship network of co-authors of Xiaoyan Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Ding. A scholar is included among the top collaborators of Xiaoyan Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Ding. Xiaoyan Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Ming‐Kung, Ke Li, Jiabin Wu, et al.. (2025). Ginsenoside Rg1: A bioactive therapeutic agent for diverse liver diseases. Pharmacological Research. 212. 107571–107571. 4 indexed citations
2.
Liu, Xiaomin, et al.. (2024). The clinical significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib and PD-1 inhibitors. Frontiers in Immunology. 15. 1380477–1380477. 3 indexed citations
3.
Ding, Xiaoyan, et al.. (2024). Transcatheter arterial chemoembolization combined with PD-1 inhibitors and Lenvatinib for hepatocellular carcinoma with portal vein tumor thrombus. World Journal of Gastroenterology. 30(8). 843–854. 7 indexed citations
4.
Cao, Jianzhong, Yue Sun, Xiaoyan Ding, et al.. (2024). [Arbutin ameliorates liver fibrosis in mice by inhibiting macrophage recruitment and regulating the Akt/NF-κB and Smad signaling pathways].. PubMed. 44(4). 652–659. 2 indexed citations
5.
Wang, Jingyan, Xiaoyan Ding, Yawen Xu, et al.. (2023). Clinical study of lenvatinib in the treatment of hepatitis virus-related hepatocellular carcinoma and antiviral therapy. Frontiers in Pharmacology. 13. 1032881–1032881. 4 indexed citations
6.
Ding, Xiaoyan, Mei Liu, Jingyan Wang, et al.. (2023). A multicenter prospective study of TACE combined with lenvatinib and camrelizumab for hepatocellular carcinoma with portal vein tumor thrombus. Cancer Medicine. 12(16). 16805–16814. 11 indexed citations
7.
Ding, Xiaoyan, et al.. (2022). Treatment options for unresectable hepatocellular carcinoma with hepatitis virus infection following sorafenib failure. Cancer Immunology Immunotherapy. 72(6). 1395–1403. 4 indexed citations
8.
Sun, Wei, et al.. (2022). Prognostic model of immune checkpoint inhibitors combined with anti-angiogenic agents in unresectable hepatocellular carcinoma. Frontiers in Immunology. 13. 1060051–1060051. 5 indexed citations
9.
10.
11.
Wang, Huige, et al.. (2020). Prognostic significance of preoperative circulating FAR and FCI scores in patients with ovarian cancer. Clinica Chimica Acta. 509. 252–257. 1 indexed citations
12.
13.
14.
15.
Ma, Fei, Huihui Li, Yiqun Li, et al.. (2017). Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC). Medicine. 96(14). e6561–e6561. 51 indexed citations
16.
Wang, Shan, Yao Ding, Xiaoyan Ding, et al.. (2016). Effectiveness of ketogenic diet in pentylenetetrazol-induced and kindling rats as well as its potential mechanisms. Neuroscience Letters. 614. 1–6. 7 indexed citations
17.
Yuan, Peng, Feng Du, Ruoxi Hong, et al.. (2016). SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple negative breast cancer. Oncotarget. 7(47). 76628–76634. 51 indexed citations
18.
Fan, Ying, Xiaoyan Ding, Binghe Xu, et al.. (2015). Prognostic Significance of Single Progesterone Receptor Positivity. Medicine. 94(46). e2066–e2066. 21 indexed citations
19.
Guo, Yi, Xiaoyan Ding, Chun‐Hong Shen, et al.. (2015). Depression and anxiety are associated with reduced antiepileptic drug adherence in Chinese patients. Epilepsy & Behavior. 50. 91–95. 40 indexed citations
20.
Mu, Lin, et al.. (2009). Decreased expression of Beclin 1 in eutopic endometrium of women with adenomyosis. Archives of Gynecology and Obstetrics. 282(4). 401–406. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catia Lippolis Breakdown of academic impact, for papers by Liangcai Wu Breakdown of academic impact, for papers by Chen Huang Breakdown of academic impact, for papers by Annalisa Lorenzato Breakdown of academic impact, for papers by Gonzalo Carrasco-Aviño Breakdown of academic impact, for papers by Thomas Grünberger Breakdown of academic impact, for papers by Thorsten Lehmann Breakdown of academic impact, for papers by Elizabeth Pang Breakdown of academic impact, for papers by Yifeng Tao Breakdown of academic impact, for papers by Takehiro Sando
Rankless by CCL
2026